Introducing GE’s NEW Molecular Breast Imaging
At EANM 2011, GE Healthcare launched its new Molecular Breast Imaging device that’s now available in Europe.
The new Discovery* NM750b is designed to help you make critical contributions to breast-cancer care, from diagnosis and planning through treatment monitoring.
It consistently provides high sensitivity, even in patients with dense breasts by detection of metabolic uptake, in a highly efficient and affordable device.
Leading-edge, CZT detectors are the primary enabler of this compact device, allowing you to image the breast up close, right up to the chest wall. This small system places the detectors close to the breast tissue in standard mammographic views allowing detection of smaller lesions than General Purpose cameras.
Best of all, the Discovery* NM750b is both patient and user friendly. It requires only light immobilization pressure, and offers efficiency in support functions from image sharing through calibration.
The Discovery* NM750b can help you provide your patient with exceptional breast care. Please contact your GE representative for additional details
